iiinova — where your digital self keeps evolving

Justin Van Beusecum @jvanbeusecumlab.bsky.social · 23/04/2025

Thank you so much! I am honored and excited to pursue this exciting project! @lupusresearch.bsky.social

Justin Van Beusecum @jvanbeusecumlab.bsky.social · 29/03/2025

Beyond proud of Marice for his fantastic presentation on his most recent findings for his dissertation work, which led to being awarded the best presentation by a graduate student at @MedUnivSC Department of Medicine Research Day! Proud to be his mentor and well-deserved!

030

Reposted by Justin Van Beusecum

American Journal of Hypertension @amjhypertension.bsky.social · 05/03/2025

Blood Pressure Management Strategies and Podocyte Health It's all about that...podocyte health *singing #MeghanTrainor in my head... academic.oup.com/ajh/issue/38/2 🔒 @opalygin.bsky.social @jvanbeusecumlab.bsky.social

0127

Reposted by Justin Van Beusecum

Lupus Foundation of America @lupus.org · 24/02/2025

💜 This #BlackHistoryMonth, we’re raising awareness of #lupus symptoms and the importance of early detection. Lupus affects many areas of the body, from the skin to the kidneys, and its symptoms can go unnoticed. Share this graphic, help yourself and others recognize signs early.

0153

Justin Van Beusecum @jvanbeusecumlab.bsky.social · 15/02/2025

I had the fantastic oppurtunity to visit with @arielpolizio.bsky.social and the Robert M. Berne Cardiovascular Research Center at the University of Virginia. It was amazing to interact with passionate trainees and faculty members and present our recent findings. Thank you so much for the invitation!

041

Reposted by Justin Van Beusecum

NEJM.org @nejm.org · 11/02/2025

In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor antagonist atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. Full ALIGN trial results: nej.md/3NzvISW #MedSky #Nephrology

Atrasentan for IgA Nephropathy

A Research Summary based on Heerspink HJL et al. | 10.1056/NEJMoa2409415 | Published on October 25, 2024

0209

Reposted by Justin Van Beusecum

Journal of Clinical Investigation @jci.org · 05/02/2025

How do renal cells regulate kidney repair after damage involving reduced blood flow? Pinelopi P. Kapitsinou & team show inactivation of the endothelial oxygen sensors PHD1-3 promotes maladaptive kidney repair and identify MCT4 as a potential therapeutic target: www.jci.org/articles/view/17…

151

Justin Van Beusecum @jvanbeusecumlab.bsky.social · 03/02/2025

Dr. Oleg Playgin and I are excited to head the new MUSC Kidney Translational Research Center (KTRC)! We have assembled a fantastic team of directors, scientists, and trainees for our established biobank and repository for kidney, adipose and vascular tissues. medicine.musc.edu/departments/...

medicine.musc.edu

Kidney Translational Research Center

The Kidney Translational Research Center (KTRC) is dedicated to advancing our understanding of vascular and renal physiology.

020

Reposted by Justin Van Beusecum

Lupus Foundation of America @lupus.org · 28/01/2025

💜 In 2024 1,200+ people joined RAY, the LFA's patient and caregiver registry, advancing #lupus research. Together, we supported clinical trials in lupus nephritis, discoid lupus, and cell therapy, bringing us closer to better treatments and cures. Join RAY today: buff.ly/3rHnFsZ

051

Justin Van Beusecum @jvanbeusecumlab.bsky.social · 26/01/2025

As Co-Organizers, we are thrilled to announced the 19th International Conference on Endothelin Research: From New Discoveries to New Treatments! Please see the Save the Date below.

19th International Conference on Endothelin Research Save the Date

022